FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32359811000001107: Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    97694501000001119 Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    97694601000001115 Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) Is a Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray false Inferred relationship Existential restriction modifier
    Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) Has active ingredient Azelastine false Inferred relationship Existential restriction modifier
    Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) Has active ingredient Fluticasone false Inferred relationship Existential restriction modifier
    Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) Has specific active ingredient Azelastine hydrochloride false Inferred relationship Existential restriction modifier
    Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) Has specific active ingredient Fluticasone propionate false Inferred relationship Existential restriction modifier
    Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) Has dispensed dose form Spray dose form false Inferred relationship Existential restriction modifier
    Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
    Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) Is a Actual medicinal product false Inferred relationship Existential restriction modifier
    Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) Has manufactured dose form Spray dose form false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) 120 dose Has AMP False Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start